The Role of Ca2+-ATPase 2a (ATP2A2), Ryanodine Receptors (RYR2), and Calsequestrin (CASQ2) Gene Polymorphisms in the Development of Heart Failure

[1]  T. Fernandes,et al.  Exercise training restores the cardiac microRNA-1 and −214 levels regulating Ca2+ handling after myocardial infarction , 2015, BMC Cardiovascular Disorders.

[2]  Ó. Cano,et al.  A new mutation in the ryanodine receptor 2 gene (RYR2 C2277R) as a cause catecholaminergic polymorphic ventricular tachycardia. , 2015, Revista espanola de cardiologia.

[3]  S. Afanas'ev,et al.  Expression of Ca2+-ATPase in Sarcoplasmic Reticulum in Rat Cardiomyocytes during Experimental Postinfarction Cardiosclerosis and Diabetes Mellitus , 2014, Bulletin of Experimental Biology and Medicine.

[4]  M. Malloy,et al.  Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease. , 2014, Heart rhythm.

[5]  R. Cappato,et al.  Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure , 2013, Journal of Interventional Cardiac Electrophysiology.

[6]  James D. Johnson,et al.  Cardiomyocyte ATP Production, Metabolic Flexibility, and Survival Require Calcium Flux through Cardiac Ryanodine Receptors in Vivo* , 2013, The Journal of Biological Chemistry.

[7]  D. Glavač,et al.  MicroRNAs and cardiac sarcoplasmic reticulum calcium ATPase-2 in human myocardial infarction: expression and bioinformatic analysis , 2012, BMC Genomics.

[8]  Amy D. Hanna,et al.  Regulation and dysregulation of cardiac ryanodine receptor (RyR2) open probability during diastole in health and disease , 2012, The Journal of general physiology.

[9]  M. Faggioni,et al.  Calsequestrin 2 and arrhythmias. , 2012, American journal of physiology. Heart and circulatory physiology.

[10]  K. Tsaneva-Atanasova,et al.  FKBP12 Activates the Cardiac Ryanodine Receptor Ca2+-Release Channel and Is Antagonised by FKBP12.6 , 2012, PloS one.

[11]  A. Leenhardt,et al.  Catecholaminergic Polymorphic Ventricular Tachycardia , 2012, Circulation. Arrhythmia and electrophysiology.

[12]  M. Cannell,et al.  Mechanisms of reduced contractility in an animal model of hypertensive heart failure , 2011, Clinical and experimental pharmacology & physiology.

[13]  E. Kizana,et al.  SUMO1-dependent modulation of SERCA2a in heart failure , 2011, Nature.

[14]  Weili Zhang,et al.  Common RyR2 variants associate with ventricular arrhythmias and sudden cardiac death in chronic heart failure. , 2010, Clinical science.

[15]  K. Kawecka-Jaszcz,et al.  [Role of the M235T (c.704c>T) polymorphism of angiotensynogen gene as well as A724A (c.2171G>A) polymorphism of SERCA2a gene in ethiopathogenesis of left ventricular hypertrophy in essential hypertension]. , 2010, Przeglad lekarski.

[16]  Weili Zhang,et al.  Common RyR 2 variants associate with ventricular arrhythmias and sudden cardiac death in chronic heart failure , 2010 .

[17]  S. Lehnart,et al.  Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart , 2009, Heart Failure Reviews.

[18]  S. Bustin,et al.  Quantification strategies in real-time PCR , 2008 .

[19]  Y. Takewa,et al.  Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts. , 2007, American journal of physiology. Heart and circulatory physiology.

[20]  R. Hajjar,et al.  Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model. , 2007, American journal of physiology. Heart and circulatory physiology.

[21]  S. Priori,et al.  Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death , 2006, Circulation research.

[22]  S. Reiken,et al.  Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[24]  K. Brown,et al.  Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia , 2001, Circulation.

[25]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[26]  Marvin A. Konstam,et al.  Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management , 2000 .

[27]  C. Franzini-armstrong.  The sarcoplasmic reticulum and the control of muscle contraction , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.